Work

811MO An exploratory study to assess the safety, immunogenicity, and preliminary anti-tumor activity of the EBV mRNA vaccine (WGc-043 injection) in patients with NK/T cell lymphoma

FWCI: 0.162
Cites:
Cited by: 1
Related to: 10